Skip to content

Supporting Caregivers During Ambulatory Cancer Surgery: Feasibility and Acceptability of a Brief Mindfulness-Based Intervention to Reduce Anxiety.

Seminars in Oncology Nursing February 19, 2026 DOI: 10.1016/j.soncn.2026.152149 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pilot feasibility study, primarily quantitative pre-post design Peer reviewed
Sample size 49
Population Informal caregivers of patients undergoing ambulatory cancer surgery, recruited in the surgical waiting room
Interventions Mindfulness meditation guided mindfulness-based audio intervention
Duration 5-minute guided mindfulness meditation; assessments immediately before and after the intervention
Measures Visual Analogue Scale for Anxiety (VAS-A), satisfaction rating, perceived effectiveness rating, likelihood of future use rating, open-ended survey responses
Topics Anxiety Meditation
Key points A brief, self-administered mindfulness meditation delivered via personal devices was feasible and acceptable to caregivers in an ambulatory oncology waiting room, and mean anxiety scores decreased from 5.67 to 4.41 immediately after the intervention. The authors report that predefined feasibility thresholds were met and call for future studies to evaluate effectiveness across diverse settings and reduce technical barriers.

Abstract

Objectives: Caregivers of patients undergoing ambulatory cancer surgery frequently experience heightened anxiety while having limited access to real-time psychosocial support. This study evaluated the feasibility, acceptability, and preliminary effects of a brief, self-guided mindfulness-based audio intervention delivered in the surgical waiting room.

Methods: This pilot feasibility study used a primarily quantitative pre-post design. Informal caregivers were recruited via QR code with support from perioperative nurse liaisons. Participants completed the Visual Analogue Scale for Anxiety (VAS-A) immediately before and after a 5-minute guided mindfulness meditation and rated satisfaction, perceived effectiveness, and likelihood of future use. Feasibility was assessed using enrollment and completion rates. Brief open-ended survey responses were collected to descriptively contextualize feasibility and acceptability findings.

Results: Of 73 caregivers who accessed the study, 49 (67.1%) enrolled. Among enrolled participants, 44 (89.8%) completed the preintervention assessment and meditation, and 27 (55.1%) completed both pre- and postintervention assessments, meeting predefined feasibility thresholds. Mean anxiety scores decreased significantly from pre- to postintervention (5.67 to 4.41; t(26) = 4.49, P < .001). Acceptability ratings exceeded the neutral midpoint (>3.0) on a five-point scale. Descriptive feedback highlighted the calming quality of the guided audio and appreciation for self-care messaging, alongside minor technical challenges related to volume, background noise, and audio playback.

Conclusions: A brief, self-administered mindfulness meditation delivered via personal devices was feasible, acceptable, and associated with reduced caregiver anxiety in an ambulatory oncology setting. Implications for practice: Ultra-brief, technology-enabled mindfulness interventions can be integrated into perioperative workflows to address acute caregiver distress without disrupting care delivery. Oncology nurses are well positioned to facilitate implementation of such low-burden supports, which may enhance caregiver well-being and preparedness for postoperative care. Future studies should evaluate effectiveness across diverse settings and optimize delivery to minimize technical barriers.

Comparable studies

Other non-randomized and open-label trials on anxiety, most cited first.

Study Year Design Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD) 2006 Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe... 2020 Open-label study

Citations in the library

Explore topics